These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15892300)

  • 61. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential incorporation of tau isoforms in Alzheimer's disease.
    Espinoza M; de Silva R; Dickson DW; Davies P
    J Alzheimers Dis; 2008 May; 14(1):1-16. PubMed ID: 18525123
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pick Complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy.
    Kertesz A
    Neurologist; 2003 Nov; 9(6):311-7. PubMed ID: 14629785
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration.
    Takanashi M; Mori H; Arima K; Mizuno Y; Hattori N
    Brain Res Mol Brain Res; 2002 Aug; 104(2):210-9. PubMed ID: 12225876
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cells.
    Woerman AL; Aoyagi A; Patel S; Kazmi SA; Lobach I; Grinberg LT; McKee AC; Seeley WW; Olson SH; Prusiner SB
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8187-E8196. PubMed ID: 27911827
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene.
    Pickering-Brown SM; Richardson AM; Snowden JS; McDonagh AM; Burns A; Braude W; Baker M; Liu WK; Yen SH; Hardy J; Hutton M; Davies Y; Allsop D; Craufurd D; Neary D; Mann DM
    Brain; 2002 Apr; 125(Pt 4):732-51. PubMed ID: 11912108
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration.
    Lipton AM; White CL; Bigio EH
    Acta Neuropathol; 2004 Nov; 108(5):379-85. PubMed ID: 15351890
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Yagishita S; Takamatsu J
    Neuroreport; 2001 Apr; 12(5):935-8. PubMed ID: 11303763
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New insights into biological markers of frontotemporal lobar degeneration spectrum.
    Borroni B; Alberici A; Archetti S; Magnani E; Di Luca M; Padovani A
    Curr Med Chem; 2010; 17(10):1002-9. PubMed ID: 20156164
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization of tau oligomeric seeds in progressive supranuclear palsy.
    Gerson JE; Sengupta U; Lasagna-Reeves CA; Guerrero-Muñoz MJ; Troncoso J; Kayed R
    Acta Neuropathol Commun; 2014 Jun; 2():73. PubMed ID: 24927818
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
    Scaravilli T; Tolosa E; Ferrer I
    Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Nonaka T; Hasegawa M; Ishiguro K; Iritani S; Tsuchiya K; Iseki E; Yagishita S; Oda T; Mochizuki A
    Ann Neurol; 2004 Jan; 55(1):72-9. PubMed ID: 14705114
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration.
    Josephs KA; Tsuboi Y; Cookson N; Watt H; Dickson DW
    Arch Neurol; 2004 Oct; 61(10):1579-84. PubMed ID: 15477512
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.
    Mukherjee O; Pastor P; Cairns NJ; Chakraverty S; Kauwe JS; Shears S; Behrens MI; Budde J; Hinrichs AL; Norton J; Levitch D; Taylor-Reinwald L; Gitcho M; Tu PH; Tenenholz Grinberg L; Liscic RM; Armendariz J; Morris JC; Goate AM
    Ann Neurol; 2006 Sep; 60(3):314-22. PubMed ID: 16983685
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration.
    Bussière T; Hof PR; Mailliot C; Brown CD; Caillet-Boudin ML; Perl DP; Buée L; Delacourte A
    Acta Neuropathol; 1999 Mar; 97(3):221-30. PubMed ID: 10090668
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lateral geniculate body is spared of tau pathology in Pick disease.
    Chang K; Barrett A; Pham K; Troncoso JC
    J Neuropathol Exp Neurol; 2024 Mar; 83(4):238-244. PubMed ID: 38412343
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsy.
    Gibb GM; de Silva R; Revesz T; Lees AJ; Anderton BH; Hanger DP
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):95-101. PubMed ID: 14969740
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes.
    Short RA; Graff-Radford NR; Adamson J; Baker M; Hutton M
    Arch Neurol; 2002 Apr; 59(4):611-5. PubMed ID: 11939896
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC).
    Miklossy J; Steele JC; Yu S; McCall S; Sandberg G; McGeer EG; McGeer PL
    Acta Neuropathol; 2008 Dec; 116(6):625-37. PubMed ID: 18843496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.